Validation of a point-of-care assay for simultaneous quantification of equine adrenocorticotropic hormone and corticotropin-like intermediate peptide
Journal of Veterinary Internal Medicine · 2026
DOI: 10.1093/jvimsj/aalag253 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Kelsey A Hart und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA 30602, United States. Hauptthemen laut MEDLINE: Adrenocorticotropic Hormone, Point-of-Care Systems, Pituitary Diseases, Horse Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Zomedica, Inc., University of Georgia Foundation.
Abstract (Originalsprache)
Background
Plasma adrenocorticotropic hormone (ACTH) concentrations are used to diagnose equine pituitary pars intermedia dysfunction (PPID). The reference chemiluminescent immunoassay for immunoreactive ACTH (iACTH) cross-reacts with corticotropin-like intermediate peptide (CLIP), which is also abnormally high in PPID. Hypothesis/Objectives To compare the performance of a novel point-of-care (POC) immunoassay that concurrently measures ACTH and CLIP against the reference iACTH assay. Animals Twenty-eight university-owned horses (13 PPID, 15 non-PPID).
Methods
Prospective observational study. Resting plasma hormone concentrations in all animals were measured by both methods in all seasons over 1 year, and after thyrotropin releasing hormone (TRH)-stimulation testing once. Bias of the POC-ACTH/CLIP assay was assessed using Spearman correlation analysis and Bland–Altman plots, and precision and linearity of the POC-ACTH/CLIP assay were determined.
Results
For resting and TRH-stimulated ACTH concentrations, the POC-ACTH/CLIP assay and the reference method had good agreement overall (r ≥ 0.94; P < .001) and in PPID animals (r = 0.93, P < .001). Bias was greater in autumn (33.6-35.6 ± 89.5-96 pg/mL) compared to winter/spring (1.6-11.1 ± 8.4-29.6 pg/mL) and in samples with ACTH concentrations ≥ 90 pg/mL (87.8 ± 116.4 pg/mL). Intra- and inter-assay coefficients of variation for the POC-ACTH/CLIP assay were 8.47% and 14.1%, respectively, and assay linearity was excellent (R2 = 0.991). Conclusions and clinical importance These data demonstrate acceptable field performance for the POC-ACTH/CLIP assay and good agreement with the chemiluminescent iACTH immunoassay, with a larger bias in samples with higher hormone concentrations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Large Animal Medicine, University of Georgia College of Veterinary Medicine, Athens, GA 30602, United States.
- Zomedica®, Inc; Plymouth, MN, United States.
Förderung
- Zomedica, Inc.
- University of Georgia Foundation
Zitieren
APA
Hart, K. A., Berghaus, L. J., & Harmon, I. (2026). Validation of a point-of-care assay for simultaneous quantification of equine adrenocorticotropic hormone and corticotropin-like intermediate peptide. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalag253
Vancouver
Hart KA, Berghaus LJ, Harmon I. Validation of a point-of-care assay for simultaneous quantification of equine adrenocorticotropic hormone and corticotropin-like intermediate peptide. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalag253
BibTeX
@article{Hart2026,
author = {Hart, Kelsey A and Berghaus, Londa J and Harmon, Ian},
title = {Validation of a point-of-care assay for simultaneous quantification of equine adrenocorticotropic hormone and corticotropin-like intermediate peptide},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
doi = {10.1093/jvimsj/aalag253}
}
EUVIMED